Drug Type Biological products |
Synonyms |
Target |
Mechanism GPNMB inhibitors(Transmembrane glycoprotein NMB inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Preclinical | US | 15 Jul 2024 |